Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics Statistics

Total Valuation

APGE has a market cap or net worth of $5.09 billion. The enterprise value is $4.52 billion.

Market Cap	5.09B
Enterprise Value	4.52B

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

APGE has 67.49 million shares outstanding. The number of shares has increased by 9.78% in one year.

Current Share Class	54.00M
Shares Outstanding	67.49M
Shares Change (YoY)	+9.78%
Shares Change (QoQ)	+0.59%
Owned by Insiders (%)	1.98%
Owned by Institutions (%)	76.33%
Float	46.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	7.64
P/TBV Ratio	8.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.86, with a Debt / Equity ratio of 0.02.

Current Ratio	15.86
Quick Ratio	15.62
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -38.41% and return on invested capital (ROIC) is -26.38%.

Return on Equity (ROE)	-38.41%
Return on Assets (ROA)	-25.26%
Return on Invested Capital (ROIC)	-26.38%
Return on Capital Employed (ROCE)	-47.87%
Revenue Per Employee	n/a
Profits Per Employee	-$1.29M
Employee Count	196
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, APGE has paid $234,000 in taxes.

Income Tax	234,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +62.99% in the last 52 weeks. The beta is 1.42, so APGE's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	+62.99%
50-Day Moving Average	56.16
200-Day Moving Average	42.40
Relative Strength Index (RSI)	76.33
Average Volume (20 Days)	749,621

Short Selling Information

The latest short interest is 7.93 million, so 11.75% of the outstanding shares have been sold short.

Short Interest	7.93M
Short Previous Month	7.95M
Short % of Shares Out	11.75%
Short % of Float	17.02%
Short Ratio (days to cover)	10.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-283.42M
Pretax Income	-253.44M
Net Income	-253.67M
EBITDA	-282.33M
EBIT	-283.42M
Earnings Per Share (EPS)	-$4.36

Balance Sheet

The company has $527.29 million in cash and $9.85 million in debt, giving a net cash position of $579.08 million or $8.58 per share.

Cash & Cash Equivalents	527.29M
Total Debt	9.85M
Net Cash	579.08M
Net Cash Per Share	$8.58
Equity (Book Value)	586.34M
Book Value Per Share	9.89
Working Capital	506.05M

Cash Flow

In the last 12 months, operating cash flow was -$232.48 million and capital expenditures -$5.08 million, giving a free cash flow of -$237.56 million.

Operating Cash Flow	-232.48M
Capital Expenditures	-5.08M
Free Cash Flow	-237.56M
FCF Per Share	-$3.52

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APGE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.78%
Shareholder Yield	-9.78%
Earnings Yield	-4.98%
FCF Yield	-4.66%

Analyst Forecast

The average price target for APGE is $99.57, which is 32.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$99.57
Price Target Difference	32.06%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1